Avion Wealth’s Microbot Medical MBOT Stock Holding History

Avion Wealth’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3K	Hold	1,500	–	–	﹤0.01%	796
2025 Q4	$3K	Buy	1,500 +500	+50%	+$1.18K	﹤0.01%	801
2025 Q3	$3K	Buy	+1,000	New	+$3.12K	﹤0.01%	770

Other funds holding MBOT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Avion Wealth's MBOT Position: Q1 2026 in Review

Avion Wealth held its Microbot Medical (MBOT) position steady in Q1 2026 at 1,500 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #796.

Avion Wealth first reported a position in MBOT in Q3 2025 and has held it in 3 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

Avion Wealth held 1,500 shares of Microbot Medical worth $3K as of Q1 2026.
Avion Wealth left its Microbot Medical share count unchanged in Q1 2026.
Microbot Medical made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #796 holding.
Avion Wealth first reported a position in Microbot Medical in Q3 2025 and has held it in 3 quarters since.
79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.